Skip to main content

Immatics N.V.

IMTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001809196

In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Immatics N.V. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of IMTX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4450+6
Shares21.2M21.0M−177.3K (−0.8%)
Value$237.8M$243.4M+$5.62M (+2.4%)

New holders (11)

Institutions that held Immatics N.V. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to IMTX in Q2 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC77,024$894.0K0.00%
ACT Capital Management, LLC63,500$738.0K0.38%
Mercer Global Advisors Inc29,877$347.0K0.00%
Citadel Advisors LLC29,864$347.0K0.00%
Fort Baker Capital Management LP99,077$340.0K0.10%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.28,931$336.0K0.00%
State Street Corp28,226$328.0K0.00%
Two Sigma Investments, LP13,948$162.0K0.00%
Jump Financial, LLC12,553$146.0K0.01%
State of Wyoming973$11.0K0.01%
Wolverine Asset Management LLC135$1.00K0.00%

Sold out (5)

Institutions that held Immatics N.V. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of IMTX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Avidity Partners Management LP884,600$9.92M
Tri Locum Partners LP121,743$1.36M
Crawford Lake Capital Management, LLC54,408$610.0K
FNY Investment Advisers, LLC300$3.00K
Advisor Group Holdings, Inc.200$2.00K